Skip to main content
Top
Published in: Reviews in Endocrine and Metabolic Disorders 2/2015

01-06-2015

An overview of the metabolic functions of osteocalcin

Authors: Jianwen Wei, Gerard Karsenty

Published in: Reviews in Endocrine and Metabolic Disorders | Issue 2/2015

Login to get access

Abstract

A recent unexpected development of bone biology is that bone is an endocrine organ contributing to the regulation of a number of physiological processes. One of the functions regulated by bone through osteocalcin, an osteoblast specific hormone, is glucose homeostasis. In this overview, we explain the rationale why we hypothesized that there should be a coordinated endocrine regulation between bone mass and energy metabolism. We then review the experiments that identified the endocrine function of osteocalcin and the cell biology events that allow osteocalcin to become a hormone. We also demonstrate the importance of this regulation to understand whole-body glucose homeostasis in the physiological state and in pathological conditions. Lastly we discuss the epidemiological and genetic evidence demonstrating that this function of osteocalcin is conserved in humans.
Literature
1.
go back to reference Hall TJ, Schaeublin M, Chambers TJ. The majority of osteoclasts require mRNA and protein synthesis for bone resorption in vitro. Biochem Biophys Res Commun. 1993;195:1245–53.CrossRefPubMed Hall TJ, Schaeublin M, Chambers TJ. The majority of osteoclasts require mRNA and protein synthesis for bone resorption in vitro. Biochem Biophys Res Commun. 1993;195:1245–53.CrossRefPubMed
2.
go back to reference Kim JM, Jeong D, Kang HK, Jung SY, et al. Osteoclast precursors display dynamic metabolic shifts toward accelerated glucose metabolism at an early stage of RANKL-stimulated osteoclast differentiation. Cell Physiol Biochem. 2007;20:935–46.CrossRefPubMed Kim JM, Jeong D, Kang HK, Jung SY, et al. Osteoclast precursors display dynamic metabolic shifts toward accelerated glucose metabolism at an early stage of RANKL-stimulated osteoclast differentiation. Cell Physiol Biochem. 2007;20:935–46.CrossRefPubMed
3.
4.
go back to reference Karsenty G, Kronenberg HM, Settembre C. Genetic control of bone formation. Annu Rev Cell Dev Biol. 2009;25:629–48.CrossRefPubMed Karsenty G, Kronenberg HM, Settembre C. Genetic control of bone formation. Annu Rev Cell Dev Biol. 2009;25:629–48.CrossRefPubMed
5.
go back to reference Audi L, Vargas DM, Gussinye M, Yeste D, et al. Clinical and biochemical determinants of bone metabolism and bone mass in adolescent female patients with anorexia nervosa. Pediatr Res. 2002;51:497–504.CrossRefPubMed Audi L, Vargas DM, Gussinye M, Yeste D, et al. Clinical and biochemical determinants of bone metabolism and bone mass in adolescent female patients with anorexia nervosa. Pediatr Res. 2002;51:497–504.CrossRefPubMed
6.
go back to reference Faridi MM, Ansari Z, Bhargava SK. Imprints of protein energy malnutrition on the skeleton of children. J Trop Pediatr. 1984;30:150–3.CrossRefPubMed Faridi MM, Ansari Z, Bhargava SK. Imprints of protein energy malnutrition on the skeleton of children. J Trop Pediatr. 1984;30:150–3.CrossRefPubMed
8.
go back to reference Himes JH. Bone growth and development in protein-calorie malnutrition. World Rev Nutr Diet. 1978;28:143–87.CrossRefPubMed Himes JH. Bone growth and development in protein-calorie malnutrition. World Rev Nutr Diet. 1978;28:143–87.CrossRefPubMed
9.
go back to reference Jacoangeli F, Zoli A, Taranto A, Staar Mezzasalma F, et al. Osteoporosis and anorexia nervosa: relative role of endocrine alterations and malnutrition. Eat Weight Disord. 2002;7:190–5.CrossRefPubMed Jacoangeli F, Zoli A, Taranto A, Staar Mezzasalma F, et al. Osteoporosis and anorexia nervosa: relative role of endocrine alterations and malnutrition. Eat Weight Disord. 2002;7:190–5.CrossRefPubMed
10.
go back to reference Mika C, Holtkamp K, Heer M, Gunther RW, et al. A 2-year prospective study of bone metabolism and bone mineral density in adolescents with anorexia nervosa. J Neural Transm. 2007;114:1611–8.CrossRefPubMed Mika C, Holtkamp K, Heer M, Gunther RW, et al. A 2-year prospective study of bone metabolism and bone mineral density in adolescents with anorexia nervosa. J Neural Transm. 2007;114:1611–8.CrossRefPubMed
11.
13.
14.
go back to reference Misra M, Miller KK, Bjornson J, Hackman A, et al. Alterations in growth hormone secretory dynamics in adolescent girls with anorexia nervosa and effects on bone metabolism. J Clin Endocrinol Metab. 2003;88:5615–23.CrossRefPubMed Misra M, Miller KK, Bjornson J, Hackman A, et al. Alterations in growth hormone secretory dynamics in adolescent girls with anorexia nervosa and effects on bone metabolism. J Clin Endocrinol Metab. 2003;88:5615–23.CrossRefPubMed
15.
go back to reference Soyka LA, Grinspoon S, Levitsky LL, Herzog DB, et al. The effects of anorexia nervosa on bone metabolism in female adolescents. J Clin Endocrinol Metab. 1999;84:4489–96.PubMed Soyka LA, Grinspoon S, Levitsky LL, Herzog DB, et al. The effects of anorexia nervosa on bone metabolism in female adolescents. J Clin Endocrinol Metab. 1999;84:4489–96.PubMed
16.
go back to reference Hauschka PV, Lian JB, Gallop PM. Direct identification of the calcium-binding amino acid, gamma-carboxyglutamate, in mineralized tissue. Proc Natl Acad Sci U S A. 1975;72:3925–9.PubMedCentralCrossRefPubMed Hauschka PV, Lian JB, Gallop PM. Direct identification of the calcium-binding amino acid, gamma-carboxyglutamate, in mineralized tissue. Proc Natl Acad Sci U S A. 1975;72:3925–9.PubMedCentralCrossRefPubMed
17.
go back to reference Price PA, Otsuka AA, Poser JW, Kristaponis J, et al. Characterization of a gamma-carboxyglutamic acid-containing protein from bone. Proc Natl Acad Sci U S A. 1976;73:1447–51.PubMedCentralCrossRefPubMed Price PA, Otsuka AA, Poser JW, Kristaponis J, et al. Characterization of a gamma-carboxyglutamic acid-containing protein from bone. Proc Natl Acad Sci U S A. 1976;73:1447–51.PubMedCentralCrossRefPubMed
18.
go back to reference Price PA, Poser JW, Raman N. Primary structure of the gamma-carboxyglutamic acid-containing protein from bovine bone. Proc Natl Acad Sci U S A. 1976;73:3374–5.PubMedCentralCrossRefPubMed Price PA, Poser JW, Raman N. Primary structure of the gamma-carboxyglutamic acid-containing protein from bovine bone. Proc Natl Acad Sci U S A. 1976;73:3374–5.PubMedCentralCrossRefPubMed
19.
go back to reference Desbois C, Hogue DA, Karsenty G. The mouse osteocalcin gene cluster contains three genes with two separate spatial and temporal patterns of expression. J Biol Chem. 1994;269:1183–90.PubMed Desbois C, Hogue DA, Karsenty G. The mouse osteocalcin gene cluster contains three genes with two separate spatial and temporal patterns of expression. J Biol Chem. 1994;269:1183–90.PubMed
20.
go back to reference Ducy P, Desbois C, Boyce B, Pinero G, et al. Increased bone formation in osteocalcin-deficient mice. Nature. 1996;382:448–52.CrossRefPubMed Ducy P, Desbois C, Boyce B, Pinero G, et al. Increased bone formation in osteocalcin-deficient mice. Nature. 1996;382:448–52.CrossRefPubMed
21.
go back to reference Mauro LJ, Olmsted EA, Skrobacz BM, Mourey RJ, et al. Identification of a hormonally regulated protein tyrosine phosphatase associated with bone and testicular differentiation. J Biol Chem. 1994;269:30659–67.PubMed Mauro LJ, Olmsted EA, Skrobacz BM, Mourey RJ, et al. Identification of a hormonally regulated protein tyrosine phosphatase associated with bone and testicular differentiation. J Biol Chem. 1994;269:30659–67.PubMed
22.
go back to reference Morrison DF, Mauro LJ. Structural characterization and chromosomal localization of the mouse cDNA and gene encoding the bone tyrosine phosphatase, mOST-PTP. Gene. 2000;257:195–208.CrossRefPubMed Morrison DF, Mauro LJ. Structural characterization and chromosomal localization of the mouse cDNA and gene encoding the bone tyrosine phosphatase, mOST-PTP. Gene. 2000;257:195–208.CrossRefPubMed
24.
go back to reference Poser JW, Esch FS, Ling NC, Price PA. Isolation and sequence of the vitamin K-dependent protein from human bone. Undercarboxylation of the first glutamic acid residue. J Biol Chem. 1980;255:8685–91.PubMed Poser JW, Esch FS, Ling NC, Price PA. Isolation and sequence of the vitamin K-dependent protein from human bone. Undercarboxylation of the first glutamic acid residue. J Biol Chem. 1980;255:8685–91.PubMed
25.
go back to reference Ferron M, Hinoi E, Karsenty G, Ducy P. Osteocalcin differentially regulates beta cell and adipocyte gene expression and affects the development of metabolic diseases in wild-type mice. Proc Natl Acad Sci U S A. 2008;105:5266–70.PubMedCentralCrossRefPubMed Ferron M, Hinoi E, Karsenty G, Ducy P. Osteocalcin differentially regulates beta cell and adipocyte gene expression and affects the development of metabolic diseases in wild-type mice. Proc Natl Acad Sci U S A. 2008;105:5266–70.PubMedCentralCrossRefPubMed
26.
go back to reference Ferron M, Wei J, Yoshizawa T, Ducy P, et al. An ELISA-based method to quantify osteocalcin carboxylation in mice. Biochem Biophys Res Commun. 2010;397:691–6.PubMedCentralCrossRefPubMed Ferron M, Wei J, Yoshizawa T, Ducy P, et al. An ELISA-based method to quantify osteocalcin carboxylation in mice. Biochem Biophys Res Commun. 2010;397:691–6.PubMedCentralCrossRefPubMed
27.
go back to reference Ferron M, Wei J, Yoshizawa T, Del Fattore A, et al. Insulin signaling in osteoblasts integrates bone remodeling and energy metabolism. Cell. 2010;142:296–308.PubMedCentralCrossRefPubMed Ferron M, Wei J, Yoshizawa T, Del Fattore A, et al. Insulin signaling in osteoblasts integrates bone remodeling and energy metabolism. Cell. 2010;142:296–308.PubMedCentralCrossRefPubMed
28.
go back to reference Fulzele K, Riddle RC, DiGirolamo DJ, Cao X, et al. Insulin receptor signaling in osteoblasts regulates postnatal bone acquisition and body composition. Cell. 2010;142:309–19.PubMedCentralCrossRefPubMed Fulzele K, Riddle RC, DiGirolamo DJ, Cao X, et al. Insulin receptor signaling in osteoblasts regulates postnatal bone acquisition and body composition. Cell. 2010;142:309–19.PubMedCentralCrossRefPubMed
29.
go back to reference Wei J, Ferron M, Clarke CJ, Hannun YA, et al. Bone-specific insulin resistance disrupts whole-body glucose homeostasis via decreased osteocalcin activation. J Clin Invest. 2014;124:1–13.PubMed Wei J, Ferron M, Clarke CJ, Hannun YA, et al. Bone-specific insulin resistance disrupts whole-body glucose homeostasis via decreased osteocalcin activation. J Clin Invest. 2014;124:1–13.PubMed
30.
go back to reference Garanty-Bogacka B, Syrenicz M, Rac M, Krupa B, et al. Association between serum osteocalcin, adiposity and metabolic risk in obese children and adolescents. Endokrynol Pol. 2013;64:346–52.CrossRefPubMed Garanty-Bogacka B, Syrenicz M, Rac M, Krupa B, et al. Association between serum osteocalcin, adiposity and metabolic risk in obese children and adolescents. Endokrynol Pol. 2013;64:346–52.CrossRefPubMed
31.
go back to reference Hwang YC, Jeong IK, Ahn KJ, Chung HY. The uncarboxylated form of osteocalcin is associated with improved glucose tolerance and enhanced beta-cell function in middle-aged male subjects. Diabetes Metab Res Rev. 2009;25:768–72.CrossRefPubMed Hwang YC, Jeong IK, Ahn KJ, Chung HY. The uncarboxylated form of osteocalcin is associated with improved glucose tolerance and enhanced beta-cell function in middle-aged male subjects. Diabetes Metab Res Rev. 2009;25:768–72.CrossRefPubMed
32.
go back to reference Hwang YC, Jeong IK, Ahn KJ, Chung HY (2011) Circulating osteocalcin level is associated with improved glucose tolerance, insulin secretion and sensitivity independent of the plasma adiponectin level. Osteoporos Int Hwang YC, Jeong IK, Ahn KJ, Chung HY (2011) Circulating osteocalcin level is associated with improved glucose tolerance, insulin secretion and sensitivity independent of the plasma adiponectin level. Osteoporos Int
33.
go back to reference Im JA, Yu BP, Jeon JY, Kim SH. Relationship between osteocalcin and glucose metabolism in postmenopausal women. Clin Chim Acta. 2008;396:66–9.CrossRefPubMed Im JA, Yu BP, Jeon JY, Kim SH. Relationship between osteocalcin and glucose metabolism in postmenopausal women. Clin Chim Acta. 2008;396:66–9.CrossRefPubMed
34.
go back to reference Kanazawa I, Yamaguchi T, Yamamoto M, Yamauchi M, et al. Serum osteocalcin level is associated with glucose metabolism and atherosclerosis parameters in type 2 diabetes mellitus. J Clin Endocrinol Metab. 2009;94:45–9.CrossRefPubMed Kanazawa I, Yamaguchi T, Yamamoto M, Yamauchi M, et al. Serum osteocalcin level is associated with glucose metabolism and atherosclerosis parameters in type 2 diabetes mellitus. J Clin Endocrinol Metab. 2009;94:45–9.CrossRefPubMed
35.
go back to reference Kanazawa I, Yamaguchi T, Yamauchi M, Yamamoto M, et al. Serum undercarboxylated osteocalcin was inversely associated with plasma glucose level and fat mass in type 2 diabetes mellitus. Osteoporos Int. 2011;22:187–94.CrossRefPubMed Kanazawa I, Yamaguchi T, Yamauchi M, Yamamoto M, et al. Serum undercarboxylated osteocalcin was inversely associated with plasma glucose level and fat mass in type 2 diabetes mellitus. Osteoporos Int. 2011;22:187–94.CrossRefPubMed
36.
go back to reference Kim GS, Jekal Y, Kim HS, Im JA, et al. Reduced serum total osteocalcin is associated with central obesity in Korean children. Obes Res Clin Pract. 2014;8:e201–298.CrossRefPubMed Kim GS, Jekal Y, Kim HS, Im JA, et al. Reduced serum total osteocalcin is associated with central obesity in Korean children. Obes Res Clin Pract. 2014;8:e201–298.CrossRefPubMed
37.
go back to reference Kindblom JM, Ohlsson C, Ljunggren O, Karlsson MK, et al. Plasma osteocalcin is inversely related to fat mass and plasma glucose in elderly Swedish men. J Bone Miner Res. 2009;24:785–91.CrossRefPubMed Kindblom JM, Ohlsson C, Ljunggren O, Karlsson MK, et al. Plasma osteocalcin is inversely related to fat mass and plasma glucose in elderly Swedish men. J Bone Miner Res. 2009;24:785–91.CrossRefPubMed
38.
go back to reference Levinger I, Jerums G, Stepto NK, Parker L, et al. The effect of acute exercise on undercarboxylated osteocalcin and insulin sensitivity in obese men. J Bone Miner Res. 2014. Levinger I, Jerums G, Stepto NK, Parker L, et al. The effect of acute exercise on undercarboxylated osteocalcin and insulin sensitivity in obese men. J Bone Miner Res. 2014.
39.
go back to reference Strapazzon G, De Toni L, Foresta C. Serum undercarboxylated osteocalcin was inversely associated with plasma glucose level and fat mass in type 2 diabetes mellitus. Osteoporos Int. 2011;22:1643–4.CrossRefPubMed Strapazzon G, De Toni L, Foresta C. Serum undercarboxylated osteocalcin was inversely associated with plasma glucose level and fat mass in type 2 diabetes mellitus. Osteoporos Int. 2011;22:1643–4.CrossRefPubMed
40.
go back to reference Wedrychowicz A, Stec M, Sztefko K, Starzyk JB. Associations between Bone, Fat Tissue and Metabolic Control in Children and Adolescents with Type 1 Diabetes Mellitus. Exp Clin Endocrinol Diabetes. 2014;122:491–5.CrossRefPubMed Wedrychowicz A, Stec M, Sztefko K, Starzyk JB. Associations between Bone, Fat Tissue and Metabolic Control in Children and Adolescents with Type 1 Diabetes Mellitus. Exp Clin Endocrinol Diabetes. 2014;122:491–5.CrossRefPubMed
41.
go back to reference Zhou M, Ma X, Li H, Pan X, et al. Serum osteocalcin concentrations in relation to glucose and lipid metabolism in Chinese individuals. Eur J Endocrinol. 2009;161:723–9.CrossRefPubMed Zhou M, Ma X, Li H, Pan X, et al. Serum osteocalcin concentrations in relation to glucose and lipid metabolism in Chinese individuals. Eur J Endocrinol. 2009;161:723–9.CrossRefPubMed
43.
go back to reference Wellendorph P, Brauner-Osborne H. Molecular cloning, expression, and sequence analysis of GPRC6A, a novel family C G-protein-coupled receptor. Gene. 2004;335:37–46.CrossRefPubMed Wellendorph P, Brauner-Osborne H. Molecular cloning, expression, and sequence analysis of GPRC6A, a novel family C G-protein-coupled receptor. Gene. 2004;335:37–46.CrossRefPubMed
44.
go back to reference Pi M, Faber P, Ekema G, Jackson PD, et al. Identification of a novel extracellular cation-sensing G-protein-coupled receptor. J Biol Chem. 2005;280:40201–9.PubMedCentralCrossRefPubMed Pi M, Faber P, Ekema G, Jackson PD, et al. Identification of a novel extracellular cation-sensing G-protein-coupled receptor. J Biol Chem. 2005;280:40201–9.PubMedCentralCrossRefPubMed
45.
go back to reference Wei J, Hanna T, Suda N, Karsenty G, et al. Osteocalcin promotes beta-cell proliferation during development and adulthood through Gprc6a. Diabetes. 2014;63:1021–31.PubMedCentralCrossRefPubMed Wei J, Hanna T, Suda N, Karsenty G, et al. Osteocalcin promotes beta-cell proliferation during development and adulthood through Gprc6a. Diabetes. 2014;63:1021–31.PubMedCentralCrossRefPubMed
46.
go back to reference Boisen KA, Main KM, Rajpert-De Meyts E, Skakkebaek NE. Are male reproductive disorders a common entity? The testicular dysgenesis syndrome. Ann N Y Acad Sci. 2001;948:90–9.CrossRefPubMed Boisen KA, Main KM, Rajpert-De Meyts E, Skakkebaek NE. Are male reproductive disorders a common entity? The testicular dysgenesis syndrome. Ann N Y Acad Sci. 2001;948:90–9.CrossRefPubMed
47.
go back to reference Glass AR, Vigersky RA. Testicular reserve of testosterone precursors in primary testicular failure. Fertil Steril. 1982;38:92–6.PubMed Glass AR, Vigersky RA. Testicular reserve of testosterone precursors in primary testicular failure. Fertil Steril. 1982;38:92–6.PubMed
49.
go back to reference Winters SJ, Troen P. A reexamination of pulsatile luteinizing hormone secretion in primary testicular failure. J Clin Endocrinol Metab. 1983;57:432–5.CrossRefPubMed Winters SJ, Troen P. A reexamination of pulsatile luteinizing hormone secretion in primary testicular failure. J Clin Endocrinol Metab. 1983;57:432–5.CrossRefPubMed
50.
go back to reference Oury F, Ferron M, Huizhen W, Confavreux C, et al. Osteocalcin regulates murine and human fertility through a pancreas-bone-testis axis. J Clin Invest. 2013;123:2421–33.PubMedCentralCrossRefPubMed Oury F, Ferron M, Huizhen W, Confavreux C, et al. Osteocalcin regulates murine and human fertility through a pancreas-bone-testis axis. J Clin Invest. 2013;123:2421–33.PubMedCentralCrossRefPubMed
Metadata
Title
An overview of the metabolic functions of osteocalcin
Authors
Jianwen Wei
Gerard Karsenty
Publication date
01-06-2015
Publisher
Springer US
Published in
Reviews in Endocrine and Metabolic Disorders / Issue 2/2015
Print ISSN: 1389-9155
Electronic ISSN: 1573-2606
DOI
https://doi.org/10.1007/s11154-014-9307-7

Other articles of this Issue 2/2015

Reviews in Endocrine and Metabolic Disorders 2/2015 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.